This is a prospective study that analyzed the factors associated with cancer progression after



Similar documents
Captivator EMR Device

Endoscopic Resection for Barrett s Esophagus and Early Cancer 2014 Masters of Minimally Invasive Surgery

Endotherapy for high grade dysplasia & early oesophageal neoplasia in Barrett s oesophagus: A single centre retrospective audit

Evolution of Barrett s esophagus

What is Barrett s esophagus? How does Barrett s esophagus develop?

Post-DDW OAG Course - Therapeutic Endoscopy

These parameters cannot, at the present time, be determined by non-invasive imaging techniques.

Learning Luncheon 7: Endoscopic Mucosal Resection: When, Where and How?

Endoscopic eradication of Barrett s esophagus

Endoscopic Submucosal Dissection (E.S.D.) vs. Endoscopic Mucosal Resection (E.M.R.) in Colombia. Advocating E.M.R.

Center for Endoscopic Research & Therapeutics

Safety of Endoscopic Mucosal Resection for Barrett s Esophagus

Barrett s oesophagus: specimen handling and reporting

Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD

EMR Can anyone do this?

National Digestive Diseases Information Clearinghouse

Cancer of the Cardia/GE Junction: Surgical Options

Photodynamic Therapy for the Treatment of Barrett s Esophagus: A Systematic Review and Economic Evaluation

Treatments for Barrett s Oesophagus

HOW I DO IT Endoscopic mucosal resection (EMR) in the esophagus

Horizon Scanning in Surgery: Application to Surgical Education and Practice

ORIGINAL ARTICLE: Clinical Endoscopy

Endoscopic Management of Barrett s High-Grade Dysplasia and Early Stage Esophageal Cancer

Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Gastroesophageal Reflux Disease (GERD) and Barrett s Esophagus (BE)

Core curriculum for EMR and ablative techniques

CPT COD1NG UPDATES Gastroenterology CPT Advisors

How to report Upper GI EMR/ESD specimens

LOWER GI ENDOSCOPIES So why is CMS yanking our chain? General Concepts for all GI Endoscopy Procedures

How to treat early gastric cancer. Surgery

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

Endoscopic mucosal resection for treatment of early gastric cancer

Figure 3. Histology; A, adenocarcinoma; B, squamous cell carcinoma

LUNG CANCER SCREENING: UNDERSTANDING LUNG NODULES LungCancerAlliance.org

Colonoscopy Data Collection Form

Barrett s Esophagus and Endoscopic Therapy

Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues

Esophageal cancer. Dr. med. Henrik Csaba Horváth

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Designed by Endoscopists, Refined by Nurses & Techs An Intuitive Endoscopic Electrosurgical Platform

Undergoing an Oesophageal Endoscopic Resection (ER)

ESD for colorectal lesions I am in favour. Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy

SAGES 2015 Flexible Endoscopy Course for Fellows

Evidence of Crohn s Disease. Case Presentation

Study Protocol Template

MU Inpatient Consult Rotation

INFORMED CONSENT FOR SLEEVE GASTRECTOMY

Endoscopic Mucosal Resection Perform with Confidence Expand your Practice. An Assessment-Based Curriculum

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization N = 50

9th Annual Rocky Mountain Interventional Endoscopy Course

Principles of training in GI endoscopy

SBRT (Elekta), 45 Gy in fractions of 3 Gy 3x/week for 5 weeks (N=22) vs.

Magnetic Anchor for More Effective Endoscopic Mucosal Resection

Endo Conference: Large Polypectomy & EMR

Thursday, November 3, 2005

The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in Breast Cancer

ERBEJET 2. The versatility of waterjet surgery: ERBEJET 2 with hybrid instruments WATERJET SURGERY

Use of stents in esophageal cancer" Hans Gerdes, M.D. Director, GI Endoscopy Unit Memorial Sloan-Kettering Cancer Center

The Need for Accurate Lung Cancer Staging

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Avinesh Pillai Department of Statistics University of Auckland New Zealand 16-Jul-2015

Billing Guideline. Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/2012 Last Update Effective: 4/16

Management of the new antiplatelets and anticoagulants

MANAGEMENT OF PATIENTS WITH EARLY ESOPHAGEAL CANCER, DYSPLASTIC AND NON-DYSPLASTIC BARRETT S ESOPHAGUS

Guidance for Peer Reviewers. The Journal of the American Osteopathic Association (JAOA)

Laparoscopic One Anastomosis Gastric Bypass (LOAGB) How I do it

How to Effectively Code for Endoscopic Procedures in Gastroenterology

Guidelines on the Preparation and Presentation of a Research or Professional Doctoral Thesis for Examination

Early Colonoscopy in Patients with Acute Diverticulitis Simon Bar-Meir, M.D.

HAVING AN ENDOSCOPIC MUCOSAL RESECTION (EMR)

POEM Procedure for. Esophageal Achalasia

MASTER OF INSTRUCTIONAL TECHNOLOGY (ITEC)

Blood-based SEPT9 Test in Colorectal Cancer Detection

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer

Endoscopic treatment of Common Esophageal disorders

Active centers: 2. Number of patients/subjects: Planned: 20 Randomized: Treated: 20 Evaluated: Efficacy: 13 Safety: 20

Optometry & Visual Performance Author Guidelines

Surgery for Esophageal Cancer

Treatment of Dysplasia in Barrett Esophagus

Transcription:

Sample Peer-Review of a Fictitious Manuscript Reviewer A s Comments to Authors: This is a prospective study that analyzed the factors associated with cancer progression after EMR of Barrett s esophagus with high-grade dysplasia. Eighty patients underwent EMR and were followed every 3 months for 1 year, and every 6 months thereafter for 3 years. Cancer progression was detected in 10%. Using multi-variate analysis, the authors noted that the presence of nodules on Barrett s mucosa and length greater than 4.5 cm were associated with cancer progression after EMR. Major Comments: 1. There was informed consent from patients but no IRB approval was mentioned. Were the patients given the option to undergo conventional care (i.e. surveillance without resection)? 2. Disclose conflicts of interest of the authors, including equipment loaned or given from medical device industry. 3. Methods. Mention the experience of each endoscopist with this type of procedure (i.e. the number of procedures performed before the study). Also mention the mean duration (minutes) of EMR, to give the readers some insight on clinical application and practicality. 4. Patients. Were there patients who received endoscopic ablative therapy (such as PDT, laser, etc) prior to entering the study? This should be part of the exclusion criteria. 5. Completeness of resection or "negative margins" after EMR should be part of the outcome measured, as done by previous authors (references given). This is an important outcome that should have been analyzed by multivariate analysis. 6. Give details regarding follow-up examinations. The authors used chromoendoscopy for surveillance. Was biopsy obtained from stained and unstained areas? From visible lesions only? 7. A paper by (reference given) showed the value of EUS for surveillance after EMR. State if EUS was used, how often, and how it affected management.

8. Results. The authors stated that the dropout rate was 5%. However, figure 3 shows cancer progression after 3 years in 8 out of 45 (not 80) patients, suggesting that the dropout rate was actually 44%. 9. The authors stated there was no statistically significant bleeding post-emr. The authors should state the exact number of patients who bled post EMR (both major and minor bleeding). This should partly assuage the readers that complications were not underreported. 10. Tables 3 and 4 provide similar information and may be combined into one table. 11. Discussion. There was no mention of the limitations of the study, one of which is the apparently high dropout rate. Also, mention how your results compare to (reference given to author) another study which was published very recently. Minor Comments 1. Figure 1 showed median values but the text showed mean values. 2. Figure 4 (endoscopic technique) is not very clear and does not show distinct details in the background. Because this can be very helpful to the reader, the author should replace this with a better quality photograph. Associate Editor s Critique of Reviewer A Ability to identify strengths and weaknesses of the study Although it raised important questions on the validity of the study, the review says nothing about the strength of the study, or whether the research question was important and if the study was original. Constructiveness of comments The reviewer provided constructive comments to the author. Level of detail of the review

The review is fairly detailed, but the reviewer missed inconsistent data between text and figures, which is a minor oversight. Substantiation of comments The reviewer made comments on the presentation with references. Was the review biased? No

Reviewer B s Comments to Authors: This manuscript tries to identify clinical and endoscopic features that would help predict cancer progression after EMR of Barrett s esophagus with high grade dysplasia. The following are my comments and critique: General: 1. The manuscript needs to be edited for grammar and syntax. 2. Abstract. This is too wordy and unhelpful. We do not need to read a litany of information in the introduction. 3. First paragraph: The authors introduce the term EMR for the first time, and need expand the abbreviation here. 4. This study is useless because there have been larger trials that have shown similar findings. Methods: 1. What was the definition of a high-grade dyplasia? Did more than one pathologist confirm high-grade dyplasia? 2. What was the definition of ulcer and nodules found on Barrett s mucosa? What size? 3. The authors used endoscopic-cap method. This should be explained more clearly. Results: 1. Under 'characteristics of the patients included': How many had esophageal strictures? 2. There is a discrepancy between the total number of patients in table 1 and the text. Which is correct? Discussion: So, based on these findings, how do we proceed with managing Barrett s esophagus with highgrade dysplasia? Do you feel the current data (yours and others) support EMR? Please elaborate and discuss.

Associate Editor s Critique of Reviewer A Ability to identify strengths and weaknesses of the study The reviewer raised questions on the validity of the study and was able to detect discrepancies between table and text. However, the reviewer mentioned nothing about the apparent lack of IRB approval in the study. Also, there were important points mixed with nitpicking, diluting the impact of the critique. Pick the big battles. Constructiveness of comments This study is useless. This comment should be deleted. Instead provide examples of previous work and compare the data. Also, the reviewer should provide specific comments on how to improve the abstract. Level of detail of the review The review is not very detailed. The critical issues in this paper were not addressed. Substantiation of comments The reviewer gave no references to support his/her comment. Was the review biased? No